Joint Cancer Therapeutics CRC/AMPLIA Therapeutics Press Release

In a rare achievement for the Australian biotechnology industry, a new potential cancer therapy developed in Australia has entered clinical trials in Melbourne. The drug invented by scientists in Cancer Therapeutics CRC will be taken into the first phase of clinical testing by Melbourne-based ASX-listed biotechnology company Amplia Therapeutics. If the clinical trials prove successful, this important discovery could be used to treat pancreatic cancer – the disease that led to the death of the prominent US Supreme Court Justice Ruth Bader Ginsburg in September this year.

To view media story please click here.